19,30-Tetratriacontadiene-2,4,6,17,33-pentayne- 1,32-diol,(19Z,30E,32R)- (182314-13-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
- 1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
- 1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
- 1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
- (19Z)-1-acetylcur-19-en-17-al
- (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
- (19Z,21E,23E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-4-O-hexopyranosylhexopyranosyl)oxy]-1,3,5,7,9,11,13,37-octahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-15-oxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,
- Peptide F (cattleadrenal medulla),1-de-L-tyrosine-2-deglycine-3-deglycine-4-de-L-phenylalanine-5-de-L-methionine-6-de-L-lysine-7-de-L-lysine-26-L-leucinamide-27-deglycine-28-de-L-lysine-29-de-L-arginine-30-de-L-tyrosine-31-deglycine-32-deglycine-33-de-L-phenylalanine-34-de-L-methionine-(9CI)
- methyl (19Z,21E,23E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-17-[6-(4-aminophenyl)-4-hydroxy-1-methyl-6-oxohexyl]-1,3,5,7,9,13,37-heptahydroxy-18-methyl-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-h
- (1R,3S,5S,7R,9R,13R,17R,18S,19Z,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-({3,6-dideoxy-3-[(N,N-dimethylglycyl)amino]-beta-D-mannopyranosyl}oxy)-N-[2-(dimethylamino)ethyl]-1,3,5,7,9,13,37-heptahydroxy-17-{(1S)-4-hydroxy-1-methyl-6-[4-(methylamino)phenyl
- methyl (19Z)-10-hydroxy-4-methyl-2,16-didehydrocur-19-en-4-ium-17-oate
- 8-32-Calcitonin (salmonreduced), N-[3-(4-hydroxyphenyl)-1-oxopropyl]-18-L-arginine-30-L-asparagine-32-L-tyrosinamide-
- 1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
- 14,20-Tricosadiene-3,5,10,12,22-pentayne-1,2-diol,1,2-bis(hydrogen sulfate), sodium salt (1:2), (2R,14Z,20Z)-
- 4,7,10,13,16,19-Docosahexaenoic acid,2-[(1-oxohexadecyl)oxy]-1,3-propanediyl ester,(4Z,4'Z,7Z,7'Z,10Z,10'Z,13Z,13'Z,16Z,16'Z,19Z,19'Z)-
- (19Z)-1-Acetyl-19,20-didehydro-17-hydroxy-10,11-dimethoxy-4-methyl-3,4-secocuran-3-one
- 19-Norpregn-4-en-20-yne-3,17-diol,3-acetate 17-[(2Z)-3-(acetyloxy)-2-butenoate], (3b,17a)- (9CI)
- 33-[(3-amino-3,6-dideoxyhexopyranosyl)oxy]-1,3,5,7,9,13,37-heptahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-11,15-dioxo-N-(2-piperidin-1-ylethyl)-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-c
- 33-[(3-amino-3,6-dideoxyhexopyranosyl)oxy]-1,3,5,7,9,13,37-heptahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-N-(2-morpholin-4-ylethyl)-11,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-c
- 33-[(3-amino-3,6-dideoxyhexopyranosyl)oxy]-1,3,5,7,9,13,37-heptahydroxy-17-{4-hydroxy-1-methyl-6-[4-(methylamino)phenyl]-6-oxohexyl}-18-methyl-11,15-dioxo-N-(2-pyridin-2-ylethyl)-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-car